DH Biotech is an established pharmaceutical business offering PCD Pharma Franchise opportunities for Injection Products in India. The company operates from Chandigarh and provides a broad range of pharmaceutical formulations covering multiple therapeutic categories. Its product portfolio includes tablets, capsules, syrups, ointments, injectables, and infusion products, allowing franchise partners to serve diverse healthcare requirements.

The company's injectable portfolio includes a variety of parenteral medicines and infusions, such as antibiotics, corticosteroid injections, pain-management products, vitamin and nutritional injections, gynecological injections, and other hospital-use formulations. Products listed in its range include ceftriaxone, piperacillin-tazobactam, meropenem, hydrocortisone, methylcobalamin, iron sucrose, and other injectable formulations.

DH Biotech operates through a PCD Pharma Franchise and monopoly distribution model, supporting business associates with product availability and pharmaceutical distribution services. The company states that its products are manufactured through trusted CGMP-certified pharmaceutical manufacturing plants, while its business operations extend across India through redistribution stockists.

With a diversified product portfolio, established distribution network, and focus on pharmaceutical quality, DH Biotech provides an opportunity for entrepreneurs seeking a Pharma Franchise Company for Injections. Its injectable and infusion range makes it particularly relevant for distributors targeting hospital, clinical, and critical-care pharmaceutical markets.